99251-1 |
Impact of best corrective lenses on halos |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Impact of best corrective lenses on halos |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.PROWL |
|
99251-1 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Best corr lens impact on halos; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99252-9 |
Seen starbursts in past 7D |
Find |
^Patient |
7D |
Ord |
|
|
ACTIVE |
Seen starbursts in past 7 days |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
EYE.HX |
|
99252-9 |
|
|
|
|
Observation |
|
|
|
0 |
Seen starbursts in past 7D |
|
|
|
N |
|
EYE; EYE.HX; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99253-7 |
Frequency of seeing starbursts when wearing best corrective lenses in past 7D |
Find |
^Patient |
7D |
Ord |
|
|
ACTIVE |
Frequency of seeing starbursts when wearing best corrective lenses in past 7 days |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.PROWL |
|
99253-7 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Frq see starbursts w best corr lens p 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99254-5 |
Frequency of seeing starbursts when not wearing corrective lenses in past 7D |
Find |
^Patient |
7D |
Ord |
|
|
ACTIVE |
Frequency of seeing starbursts when not wearing corrective lenses in past 7 days |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.PROWL |
|
99254-5 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Freq of starbursts w/o corr lens pst 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99255-2 |
How bothersome have starbursts been when wearing best corrective lenses in past 7D |
Find |
^Patient |
7D |
Ord |
|
|
ACTIVE |
How bothersome have starbursts been when wearing best corrective lenses in past 7 days |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.PROWL |
|
99255-2 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99256-0 |
How bothersome have starbursts been when not wearing corrective lenses in past 7D |
Find |
^Patient |
7D |
Ord |
|
|
ACTIVE |
How bothersome have starbursts been when not wearing corrective lenses in past 7 days |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.PROWL |
|
99256-0 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99257-8 |
Level of difficulty doing usual activities because of starbursts when wearing best corrective lenses in past 7D |
Find |
^Patient |
7D |
Ord |
|
|
ACTIVE |
Level of difficulty doing usual activities because of starbursts when wearing best corrective lenses in past 7 days |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.PROWL |
|
99257-8 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Dif lvl bc starbursts w best lens p 7D; Finding; Findings; Last; Levels; Levl; LV; LVL; Ordinal; Ql; Qual; Qualitative; Screen; Survey |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99258-6 |
Level of difficulty doing usual activities because of starbursts when not wearing corrective lenses in past 7D |
Find |
^Patient |
7D |
Ord |
|
|
ACTIVE |
Level of difficulty doing usual activities because of starbursts when not wearing corrective lenses in past 7 days |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.PROWL |
|
99258-6 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Dif lvl bc starbursts wo corr lens p 7D; Finding; Findings; Last; Levels; Levl; LV; LVL; Ordinal; Ql; Qual; Qualitative; Screen; Survey |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99259-4 |
Impact of best corrective lenses on starbursts |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Impact of best corrective lenses on starbursts |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.PROWL |
|
99259-4 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Best corr lens impact on starbursts; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
9926-7 |
Q wave depth.lead AVL |
Elpot |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
Q wave depth in lead AVL |
|
MIN |
DefinitionDescription |
|
|
mV |
|
|
|
|
|
|
EKG.MEAS |
|
9926-7 |
|
EKG |
|
|
Observation |
|
|
|
0 |
Q wave Dpth L-AVL |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; Dpth; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; Q wave Dpth; Q wave Dpth L-AVL; Q wave Dpth Lead; QNT; Quan; Quant; Quantitative; Random; Voltage |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV |
|
|
|
0 |
99260-2 |
Information source for medical procedure |
Type |
^Patient |
Pt |
Nom |
|
|
ACTIVE |
Information source for medical procedure |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.GNHLTH |
|
99260-2 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Nominal; Point in time; Random; Source of info; Srce; Survey; SURVEY.GNHLTH; Typ |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99261-0 |
Told not to have LASIK by an eye care professional |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Told not to have LASIK by an eye care professional |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.PROWL |
|
99261-0 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99262-8 |
Designer benzodiazepines |
PrThr |
Urine |
Pt |
Ord |
Confirm |
|
ACTIVE |
Designer benzodiazepines [Presence] in Urine by Confirmatory method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
99262-8 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Designer benzodiazepines Ur Ql Cfm |
|
|
|
N |
|
Benz; Benzodiaz; Benzodiazepine; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99263-6 |
Delorazepam |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Delorazepam [Mass/volume] in Urine by Confirmatory method |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
99263-6 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Delorazepam Ur Cfm-mCnc |
|
|
|
N |
|
B1, Benzodiazepine; Cfm; Cl-DMDZ; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.72 |
2.72 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
99264-4 |
Etizolam |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Etizolam [Mass/volume] in Urine by Confirmatory method |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
99264-4 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Etizolam Ur Cfm-mCnc |
|
|
|
N |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Depas; DRUG/TOXICOLOGY; Drugs; etizolam; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Y-7131 |
2.72 |
2.72 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
99265-1 |
Alpha hydroxyetizolam |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Alpha hydroxyetizolam [Mass/volume] in Urine by Confirmatory method |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
99265-1 |
|
Confirm |
|
|
Both |
|
|
|
0 |
A-OH-etizolam Ur Cfm-mCnc |
|
|
|
N |
|
Alfa; A-OH-etizolam; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.72 |
2.72 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
99266-9 |
Deschloroetizolam |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Deschloroetizolam [Mass/volume] in Urine by Confirmatory method |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
99266-9 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Deschloroetizolam Ur Cfm-mCnc |
|
|
|
N |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.72 |
2.72 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
99267-7 |
Nifoxipam |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Nifoxipam [Mass/volume] in Urine by Confirmatory method |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
99267-7 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Nifoxipam Ur Cfm-mCnc |
|
|
|
N |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.72 |
2.72 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
99268-5 |
Diclazepam |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Diclazepam [Mass/volume] in Urine by Confirmatory method |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
99268-5 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Diclazepam Ur Cfm-mCnc |
|
|
|
N |
|
2'-chloro-diazepam; 2-Chlorodiazepam; Cfm; chlorodiazepam; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Ro5-3448; UA; UR; Urn |
2.72 |
2.72 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
99269-3 |
Clonazolam |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Clonazolam [Mass/volume] in Urine by Confirmatory method |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
99269-3 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Clonazolam Ur Cfm-mCnc |
|
|
|
N |
|
Addiction; Cfm; clonitrazolam; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.72 |
2.72 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
9927-5 |
Q wave depth.lead AVR |
Elpot |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
Q wave depth in lead AVR |
|
MIN |
DefinitionDescription |
|
|
mV |
|
|
|
|
|
|
EKG.MEAS |
|
9927-5 |
|
EKG |
|
|
Observation |
|
|
|
0 |
Q wave Dpth L-AVR |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; Dpth; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; Q wave Dpth; Q wave Dpth L-AVR; Q wave Dpth Lead; QNT; Quan; Quant; Quantitative; Random; Voltage |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV |
|
|
|
0 |
99270-1 |
8-Aminoclonazolam |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
8-Aminoclonazolam [Mass/volume] in Urine by Confirmatory method |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
99270-1 |
|
Confirm |
|
|
Both |
|
|
|
0 |
8-Aminoclonazolam Ur Cfm-mCnc |
|
|
|
N |
|
Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.72 |
2.72 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
99271-9 |
Flualprazolam |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Flualprazolam [Mass/volume] in Urine by Confirmatory method |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
99271-9 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Flualprazolam Ur Cfm-mCnc |
|
|
|
N |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; flualprazolam; FWF5L8D2BE; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UNII-FWF5L8D2BE; UR; Urn |
2.72 |
2.72 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
99272-7 |
Alpha-hydroxy flualprazolam |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Alpha-hydroxy flualprazolam [Mass/volume] in Urine by Confirmatory method |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
99272-7 |
|
Confirm |
|
|
Both |
|
|
|
0 |
A-OH flualprazolam Ur Cfm-mCnc |
|
|
|
N |
|
Alfa; A-OH flualprazolam; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; flualprazolam; FWF5L8D2BE; GCMS; Hydrox; LC/MS/MS; Level; Mass concentration; OH; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UNII-FWF5L8D2BE; UR; Urn |
2.72 |
2.72 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
99273-5 |
Meclonazepam |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Meclonazepam [Mass/volume] in Urine by Confirmatory method |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
99273-5 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Meclonazepam Ur Cfm-mCnc |
|
|
|
N |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Meclonazepamum; Point in time; QNT; Quan; Quant; Quantitative; Random; RN43209SMA; UA; UR; Urn |
2.72 |
2.72 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |